A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
This study has been completed.
Mesoblast International Sàrl
First Posted: September 23, 2005
Last Update Posted: December 4, 2014
University of Southern California
Midwest Orthopedics at Rush - Chicago, IL
Unlimited Research - San Antonio, TX
Triangle Orthopaedic Associates, P.A.
Orthopedic Center of Vero Beach - Vero Beach, FL
TRIA Orthopaedic Center
Greater Chesapeake Associates - Baltimore, MD
Information provided by (Responsible Party):
Mesoblast, Ltd. ( Mesoblast International Sàrl )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2008|
|Primary Completion Date:||April 2008 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Vangsness CT Jr, Farr J 2nd, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014 Jan 15;96(2):90-8. doi: 10.2106/JBJS.M.00058.